In a move that raises eyebrows, the Biden administration has announced a $306 million investment aimed at bolstering bird flu monitoring and preparedness efforts across the United States. This initiative comes as the White House prepares to transition power to President-elect Donald Trump, leaving many conservatives questioning the timing and motives behind this sudden urgency.
The Centers for Disease Control and Prevention (CDC) confirmed the first U.S. case of avian influenza A(H5N1), commonly known as bird flu, in November. The case involved a child from California who experienced mild symptoms and has since recovered following treatment with antiviral medication.
More recently, the CDC reported a severe case of H5N1 in a 65-year-old Louisiana man who had contact with sick backyard birds. The agency and so-called “experts” are now raising alarms about the virus’s alleged mutations and its supposed potential for human transmission, fueling concerns of overreach and panic-driven narratives.
This development comes amid growing acknowledgment of the effectiveness of hydroxychloroquine in saving countless lives, as affirmed by recent studies—a vindication for President Trump, who was relentlessly criticized for promoting the treatment.
According to reports from the Associated Press, genetic analysis of the virus revealed mutations in the hemagglutinin (HA) gene that, experts claim, could increase the virus’s ability to infect humans. However, these mutations were reportedly absent in infected birds on the patient’s property, suggesting the virus may have mutated post-infection.
As the Biden regime attempts to push this narrative in its final days, conservatives remain skeptical, viewing the sudden focus on a “potential bird flu outbreak” as yet another example of government overreach and fear-mongering. With President-elect Trump set to restore confidence and accountability in government, many Americans look forward to a more measured and transparent approach to public health challenges.
